FDA Inspection 1316536 — University of Pittsburg Medical Center, Hillman Cancer Center
The FDA completed an inspection of University of Pittsburg Medical Center, Hillman Cancer Center on April 23, 2026 in Carlisle, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 23, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Carlisle, PA (United States)